Pavone Luigi Michele, Del Vecchio Pompea, Mallardo Paolo, Altieri Filomena, De Pasquale Valeria, Rea Silviana, Martucci Nicola M, Di Stadio Chiara Stella, Pucci Pietro, Flagiello Angela, Masullo Mariorosario, Arcari Paolo, Rippa Emilia
Department of Biochemistry and Medical Biotechnology, University of Naples Federico II, Via S. Pansini 5, 80131 Naples, Italy.
Mol Biosyst. 2013 Mar;9(3):412-21. doi: 10.1039/c2mb25308a. Epub 2013 Jan 14.
Gastrokine-1 (GKN1), a protein expressed in normal gastric tissue, but absent in gastric cancer tissues and derived cell lines, has recently emerged as a potential biomarker for gastric cancer. To better establish the molecular properties of GKN1, the first protocol for the production of mature human GKN1 in the expression system of Pichia pastoris was settled. The recombinant protein showed anti-proliferative properties specifically on gastric cancer cell lines thus indicating that it was properly folded. Characterization of structural and biochemical properties of recombinant GKN1 was achieved by limited proteolysis analysis, circular dichroism and fluorescence spectroscopy. The analysis of GKN1 primary structure coupled to proteolytic experiments highlighted that GKN1 was essentially resistant to proteolytic enzymes and showed the presence of at least a disulphide bond between Cys61 and one of the other three Cys (Cys122, Cys145 and Cys159) of the molecule. The secondary structure analysis revealed a prevailing β-structure. Spectroscopic and calorimetric investigations on GKN1 thermal denaturation pointed out its high thermal stability and suggested a more complex than a two-state unfolding process. The resulting protein was endowed with a globular structure characterized by domains showing different stabilities toward chemical and physical denaturants. These results are in agreement with the prediction of GKN1 secondary structure and a three-dimensional structure model. Our findings provide the basis for the development of new pharmaceutical compounds of potential use for gastric cancer therapy.
胃动素-1(GKN1)是一种在正常胃组织中表达,但在胃癌组织及其衍生细胞系中不存在的蛋白质,最近已成为一种潜在的胃癌生物标志物。为了更好地确定GKN1的分子特性,确定了在毕赤酵母表达系统中生产成熟人GKN1的首个方案。重组蛋白对胃癌细胞系具有特异性抗增殖特性,表明其折叠正确。通过有限蛋白酶解分析、圆二色性和荧光光谱对重组GKN1的结构和生化特性进行了表征。GKN1一级结构分析与蛋白水解实验相结合,突出表明GKN1对蛋白酶基本具有抗性,且在分子的Cys61与其他三个Cys(Cys122、Cys145和Cys159)之一之间至少存在一个二硫键。二级结构分析显示主要为β结构。对GKN1热变性的光谱和量热研究指出其具有高热稳定性,并表明其展开过程比两态过程更复杂。所得蛋白质具有球状结构,其结构域对化学和物理变性剂表现出不同的稳定性。这些结果与GKN1二级结构和三维结构模型的预测一致。我们的研究结果为开发潜在用于胃癌治疗的新型药物化合物提供了基础。